117 related articles for article (PubMed ID: 35598685)
1. GLP-1R polymorphism (rs1042044) and expression are associated with the risk of papillary thyroid cancer among the Egyptian population.
Abdul-Maksoud RS; Elsayed WSH; Rashad NM; Elsayed RS; Elshorbagy S; Hamed MG
Gene; 2022 Aug; 834():146597. PubMed ID: 35598685
[TBL] [Abstract][Full Text] [Related]
2. Expression of glucagon-like Peptide-1 receptor in papillary thyroid carcinoma and its clinicopathologic significance.
Jung MJ; Kwon SK
Endocrinol Metab (Seoul); 2014 Dec; 29(4):536-44. PubMed ID: 25559577
[TBL] [Abstract][Full Text] [Related]
3. MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.
Roncevic J; Djoric I; Selemetjev S; Jankovic J; Dencic TI; Bozic V; Cvejic D
Pathology; 2019 Jan; 51(1):55-61. PubMed ID: 30497805
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the glucagon-like peptide-1 receptor gene and their interactions on the risk of osteoporosis in postmenopausal Chinese women.
Liu C; Bao X; Tian Y; Xue P; Wang Y; Li Y
PLoS One; 2023; 18(12):e0295451. PubMed ID: 38096145
[TBL] [Abstract][Full Text] [Related]
5. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
[TBL] [Abstract][Full Text] [Related]
6. OPN -443C>T genetic polymorphism and tumor OPN expression are associated with the risk and clinical features of papillary thyroid cancer in a Chinese cohort.
Mu G; Wang H; Cai Z; Ji H
Cell Physiol Biochem; 2013; 32(1):171-9. PubMed ID: 23867349
[TBL] [Abstract][Full Text] [Related]
7. Effects of insulin analogs and glucagon-like peptide-1 receptor agonists on proliferation and cellular energy metabolism in papillary thyroid cancer.
He L; Zhang S; Zhang X; Liu R; Guan H; Zhang H
Onco Targets Ther; 2017; 10():5621-5631. PubMed ID: 29200876
[TBL] [Abstract][Full Text] [Related]
8. Relationship between glucagon-like peptide-1 receptor gene polymorphism and bone mineral density in postmenopausal women in Shanghai.
Zhang L; He J; Sun X; Luo X; Zeng J; He W; Liu X; Feng B
Ann Palliat Med; 2020 Jul; 9(4):1732-1741. PubMed ID: 32527131
[TBL] [Abstract][Full Text] [Related]
9. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
10. The effect of CASP3 rs4647610 and rs4647602 polymorphisms on tumour size and cancer stage in papillary thyroid carcinoma.
Heidari Z; Eskandari M; Aryan A; Rostamzad F; Salimi S
Br J Biomed Sci; 2020 Jul; 77(3):129-134. PubMed ID: 32151194
[TBL] [Abstract][Full Text] [Related]
11. Differential association between the GLP1R gene variants and brain functional connectivity according to the severity of alcohol use.
Farokhnia M; Fede SJ; Grodin EN; Browning BD; Crozier ME; Schwandt ML; Hodgkinson CA; Momenan R; Leggio L
Sci Rep; 2022 Jul; 12(1):13027. PubMed ID: 35906358
[TBL] [Abstract][Full Text] [Related]
12. Association between Genetic Polymorphisms in microRNA Machinery Genes and Risk of Papillary Thyroid Carcinoma.
Mohammadpour-Gharehbagh A; Heidari Z; Eskandari M; Aryan A; Salimi S
Pathol Oncol Res; 2020 Apr; 26(2):1235-1241. PubMed ID: 31250375
[TBL] [Abstract][Full Text] [Related]
13. Association of incretin receptors genetic polymorphisms with type 2 diabetes mellitus in Egyptian patients.
Shalaby SM; Zidan HE; Shokry A; Saeed J; El-Sokkary RH
J Gene Med; 2017 Sep; 19(9-10):. PubMed ID: 28744963
[TBL] [Abstract][Full Text] [Related]
14. Expression and significance of IGF-1 and IGF-1R in thyroid nodules.
Liu YJ; Qiang W; Shi J; Lv SQ; Ji MJ; Shi BY
Endocrine; 2013 Aug; 44(1):158-64. PubMed ID: 23288662
[TBL] [Abstract][Full Text] [Related]
15. Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A
Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578
[TBL] [Abstract][Full Text] [Related]
16. Correlation between
Zhang F; Fan G; Wang X
Biomark Med; 2022 May; 16(7):537-547. PubMed ID: 35362324
[No Abstract] [Full Text] [Related]
17. Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.
Bingül İ; Vural P; Doğru-Abbasoğlu S; Çil E; Uysal M
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 27925342
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the Glucagon-Like Peptide 1 Receptor (
Ma X; Lu R; Gu N; Wei X; Bai G; Zhang J; Deng R; Feng N; Li J; Guo X
J Diabetes Res; 2018; 2018():1054192. PubMed ID: 30271789
[TBL] [Abstract][Full Text] [Related]
19. Association between GLP-1 receptor gene polymorphisms with reward learning, anhedonia and depression diagnosis.
Yapici-Eser H; Appadurai V; Eren CY; Yazici D; Chen CY; Öngür D; Pizzagalli DA; Werge T; Hall MH
Acta Neuropsychiatr; 2020 Aug; 32(4):218-225. PubMed ID: 32213216
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population.
Erdogan M; Karadeniz M; Ozbek M; Ozgen AG; Berdeli A
J Endocrinol Invest; 2008 Sep; 31(9):750-4. PubMed ID: 18997484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
